The spliceosome as a new therapeutic vulnerability in aggressive prostate cancer
Alternative splicing (AS) analysis across the entire spectrum of human prostate cancer evolution reveals the unexpected findings that intron retention is a hallmark of stemness and tumor aggressiveness, and androgen receptor controls a splicing program distinct from its transcriptional regulation. I...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2020-09-01
|
| סדרה: | Molecular & Cellular Oncology |
| נושאים: | |
| גישה מקוונת: | http://dx.doi.org/10.1080/23723556.2020.1778420 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
